Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug-induced fluorosis]

G Strohmeyer, M Bunata

    Zeitschrift Fur Rheumatologie
    |May 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Long-term sodium fluoride treatment for osteoporosis can lead to severe fluorosis, even with normal kidney function. This case highlights potential risks despite therapeutic intent.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    EMRP project MetroMetal: selected results of ENVINET and CMI.

    Radiation protection dosimetry·2014
    Same author

    [Gastroenterology - accusations and errors in treatment: evaluation of the completed expertise process in internal medicine of the expert committee of North Rhineland for the years 2001 to 2005].

    Zeitschrift fur Gastroenterologie·2008
    Same author

    [Antibiotic-associated diarrhea].

    Deutsche medizinische Wochenschrift (1946)·2003
    Same author

    5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2003
    Same author

    Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
    Same author

    [Liver damage caused by drugs].

    Zeitschrift fur Gastroenterologie·1999
    Same journal

    [Prevention strategies in rheumatoid arthritis : From primary prevention to targeted drug interception].

    Zeitschrift fur Rheumatologie·2026
    Same journal

    Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.

    Zeitschrift fur Rheumatologie·2026
    Same journal

    Evaluating the comparative efficacy of belimumab vs. anifrolumab in systemic lupus erythematosus: a response.

    Zeitschrift fur Rheumatologie·2026
    Same journal

    [Update: DMARDs for MGUS].

    Zeitschrift fur Rheumatologie·2026
    Same journal

    [A potpourri of diagnoses-Unusual manifestations of a chronic inflammatory bowel disease : Case report].

    Zeitschrift fur Rheumatologie·2026
    Same journal

    [Not measurable but immeasurably important : Fever-The leading symptom of ancient medical theory].

    Zeitschrift fur Rheumatologie·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Nephrology
    • Skeletal biology

    Background:

    • Osteoporosis treatment often involves bone-forming agents.
    • Sodium fluoride has been investigated for its osteogenic potential.
    • Long-term safety and efficacy require careful monitoring.

    Observation:

    • A 58-year-old patient received 146g of sodium fluoride over 5 years for osteoporosis.
    • Despite treatment, the patient experienced grade II-III fluorosis (Roholm classification).
    • Renal function tests (serum creatinine, creatinine clearance) were within normal or minimally impaired limits.

    Findings:

    • Continuous sodium fluoride therapy did not alleviate skeletal pain or ensure vertebral stability.
    • New endplate impressions were observed in dorsal vertebrae, indicating disease progression.

    Related Experiment Videos

  • Fluorosis developed despite the absence of significant renal impairment.

    • Implications:

    • High-dose, long-term sodium fluoride treatment carries a risk of severe fluorosis.
    • Therapeutic goals for osteoporosis may not be met, and skeletal integrity can be compromised.
    • Careful patient selection and monitoring are crucial for fluoride-based osteoporosis therapies.